日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[The evaluation value of mNUTRIC and NRS-2002 scores in assessing nutritional status and clinical outcomes in patients with end-stage liver disease]

[mNUTRIC 和 NRS-2002 评分在评估终末期肝病患者营养状况和临床结果中的评价价值]

Yang, J Y; Mao, X R; Yang, Z H; Zhou, X J; Gou, X; Li, J F

[A phase Ⅲ clinical study to evaluate the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of adults with chronic hepatitis C]

[一项评估安替他韦磷酸盐联合依奇布韦治疗成人慢性丙型肝炎疗效和安全性的Ⅲ期临床研究]

Wei, L; Shang, J; An, X; Zhang, G Q; Guan, Y J; Piao, H X; Jin, J L; Bai, L; Yang, X X; Yang, D K; Luo, X H; Yuan, S F; Zhao, Y R; Ma, Y J; Li, G M; Lin, F; Wu, X P; Geng, J W; Zou, G Z; Chang, J B; Gong, Z J; Mao, X R; Zhu, J; Guo, W T; He, Q W; Luo, L; Zhuang, Y L; Xie, H M; Zhang, Y J

[Synchronization isolation method for multiple types of cells from mouse liver].

[小鼠肝脏多种细胞的同步分离方法]

Gan J, Ji C F, Mao X R, Wang J T, Lyu C Y, Shi Y F, Liao Y, He Y L, Shu L, Li L, Li J F

[A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection]

[一项 II 期、单臂、开放标签、多中心临床研究,旨在评估索非布韦联合利巴韦林治疗 2 型基因型慢性丙型肝炎病毒感染患者的疗效和安全性]

Gao, Y H; Li, G M; Jin, Q L; Zhao, Y R; Jia, Z S; Mao, X R; Yang, Y F; Shang, J; Wang, G C; Xie, W; Wu, S M; Zhang, M X; Hou, J L; Li, D L; Nan, Y M; Guan, Y J; Zhu, C X; Yuan, Y Z; Wei, L

Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response.

烟酰胺单核苷酸腺苷酰转移酶通过激活线粒体未折叠蛋白反应来促进缺氧存活

Mao X R, Kaufman D M, Crowder C M